Q/C Technologies, Inc. (QCLS)
NCM – Real vaqt narxi. Valyuta: USD
3.58
-0.13 (-3.50%)
Yopilishda: Jun 26, 2026, 4:00 PM EDT
3.78
+0.20 (5.59%)
Bozordan keyin: Jun 26, 2026, 6:03 PM EDT
Find any stock by ticker or company name

NCM – Real vaqt narxi. Valyuta: USD
3.58
-0.13 (-3.50%)
Yopilishda: Jun 26, 2026, 4:00 PM EDT
3.78
+0.20 (5.59%)
Bozordan keyin: Jun 26, 2026, 6:03 PM EDT
Q/C Technologies, Inc. klinik bosqichdagi farmatsevtika kompaniyasi sifatida faoliyat yuritadi. U Farmatsevtika va Kompyuter Texnologiyalari segmentlari orqali ishlaydi. Kompaniya immunitet-metabolik tizimni tartibga soluvchi, avtoimun kasalliklari, jumladan sarkopeniya, zaiflik, diabet va semirishni davolashda ishlatiladigan dorilarda kuzatiladigan nojo'ya ta'sirlar, revmatoid artrit va yallig'lanishli ichak kasalliklarini davolash uchun klinik bosqichdagi kichik molekula bo'lgan Isomyosamine'ni ishlab chiqadi. Shuningdek, u epilepsiya, og'riq va tashvish/depressiya kabi turli holatlarni davolash uchun kannabidiol (CBD) ning sintetik analog hosilasi bo'lgan Supera-CBD'ni ishlab chiqadi. Bundan tashqari, u kriptovalyuta ilovalari uchun kvant hisoblash texnologiyasini ishlab chiqish va kelajakda qo'llash bilan shug'ullanadi. Kompaniya ilgari TNF Pharmaceuticals, Inc. nomi bilan tanilgan va 2025-yil sentyabr oyida Q/C Technologies, Inc. nomini o'zgartirgan. Kompaniya 2014-yilda tashkil etilgan va Nyu-York, Nyu-York shahrida joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Mitchell Glass M.D. | Chief Medical Officer & Director |
| Mr. Ian Thomas Rhodes CPA | Chief Financial Officer |
| Mr. Joshua N. Silverman | Executive Chairman of the Board |
| Robert Schatz | Investor Relations Officer |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-05-15 | 10-Q | form10-q.htm |
| 2026-04-29 | 10-K/A | form10-ka.htm |
| 2026-04-15 | 10-K | form10-k.htm |
| 2026-03-31 | NT 10-K | formnt10-k.htm |
| 2026-03-13 | 8-K | form8-k.htm |
| 2026-02-12 | CORRESP | filename1.htm |
| 2026-02-11 | S-3 | forms-3.htm |
| 2026-01-23 | DRS | filename1.htm |
| 2026-01-23 | 8-K | form8-k.htm |
| 2025-12-09 | 8-K | form8-k.htm |